ÂÜÀòÂÒÂ×

Gregory Berger is a highly experienced professional in operations and scientific research, currently serving as the Director of Operations for virology and molecular biology at Solvias since March 2024. Prior to this role, Gregory worked as a Principal Scientist at Celonic Group from January 2022 to February 2024, and held a position as Product Manager at Sartorius Stedim Biotech for a brief period in late 2021. Gregory's extensive background includes a series of roles at the Cell and Gene Therapy Catapult from 2017 to 2021, focusing on process industrialization and development, as well as a Research Associate position at King's College London from 2012 to 2017. Earlier experience includes research at ENS Lyon, emphasizing HIV biology and the mechanisms of viral restriction in myeloid cells. Gregory holds a PhD in Virology/Immunology from ENS Lyon and multiple degrees in related fields from universities in France.